Foreword - ADHD in the scientific and political context

European Child and Adolescent Psychiatry, Supplement

Volumn 13, Issue 1, 2004, Pages

  Buitelaar, Jan K ^a   Rothenberger, Aribert ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

ADHD; Children; Debate; Europe; Politics

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; COCAINE; METHAMPHETAMINE; METHYLPHENIDATE; PLACEBO; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ANIMAL MODEL; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CHILD; CHILD PSYCHIATRY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EUROPE; HUMAN; HYPERACTIVITY; MENTAL DISEASE; NEUROTOXICITY; NONHUMAN; POLITICS; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; RAT; REVIEW; SCIENCE; SIDE EFFECT; SUBSTANCE ABUSE; SYMPTOMATOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; HEALTH EDUCATION; HUMANS; MENTAL DISORDERS; POLITICS; PSYCHIATRY;

EID: 4444221635     PISSN: 14335719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00787-004-1001-y     Document Type: Review

References (29)

1. Angold A, Erkanli A, Egger HL, Costello EJ (2000) Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 39:975-984
2. Barkley RA, Fischer M, Smallish L, Fletcher K (2003) Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 111:97-109
3. Baumgaertel A, Wolraich ML, Dietrich M (1995) Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry 34:629-638
4. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV (1999) Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104:e20
5. Burd L, Klug MG, Coumbe MJ, Kerbeshian J (2003) Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care. J Child Neurol 18:555-561
6. Council of Europe (2000) Socioculturel Factors and the Treatment of ADHD. Council of Europe, Strasbourg
7. De Jong PE (1997) Short-term trends in Dutch children's attention problems. Eur Child Adolesc Psychiatry 6:73-80
8. DeGrandpre R (1999) Ritalin Nation; Rapid-fire Culture and the Transformation of Human Consciousness. W. W. Norton and Company, New York
9. Drug Enforcement Administration (1995) Methylphenidate Review. DEA, Washington DC
10. Gomez R, Harvey J, Quick C, Scharer I, Harris G (1999) DSM-IV AD/HD: Confirmatory factor models, prevalence, and gender and age differences based on parent and teacher ratings of Australian primary school children. J Child Psychol Psychiatry 40:265-274
11. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD (1999) Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 38:797-804
12. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J (1994) DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 151:1673-1685
13. Llana ME, Crismon ML (1999) Methylphenidate: increased abuse or appropriate use? J Am Pharmaceutical Assoc 39:526-530
14. National Institutes of Health (NIH) (2000) National Institutes of Health Consensus development statement-diagnosis and treatment of Attention-deficit/ Hyperactivity Disorder (ADHD). J Am Acad Child Adolesc Psychiatry 39:182-193
15. Pollack W (1998) Real Boys: Rescuing our Sons from the Myths of Boyhood. Random House, New York
16. Rapoport JL, Buchsbaum M, Weingartner H, Zahn TP, Ludlow CL, Mikkelsen EJ (1980) Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Arch Gen Psychiatry 37:933-943
17. Rothenberger A, Banaschewski T (2002) Towards a better drug treatment for patients in Child and Adolescent Psychiatry - the European approach. Eur Child Adolesc Psychiatry 11:243-246
18. Safer DJ, Krager JM (1992) Effect of a media blitz and a threatened lawsuit on stimulant treatment. J Am Med Assoc 268:1004-1007
19. Seiden LS, Ricaurte GA (1987) Neurotoxocity of methamphetamine and related drugs. In: Meltzer HY (ed) Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp 359-366
20. Sociaal en Cultureel Planbureau (SCP) (1999) Op Weg naar Andere Tijden? SDU, Den Haag
21. Spensley J, Rockwell DA (1972) Psychosis during methylphenidate abuse. New Engl J Med 286:880-881
22. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429-433
23. Szasz T (1970) The Manufacture of Madness: A Comparative Study of the Inquisition and the Mental Health Movement. Harper & Row, New York
24. Szasz T (1961) The Myth of Mental Illness: Foundations of a Theory of Personal Conduct. Hoeper Harper, New York
25. Van Praag HM (1999) Nosologomanie, een aandoening van de psychiatrie. Tijdschrift voor Psychiatrie 12:703-712
26. Verhulst FC, Van der Ende J, Rietbergen A (1997) Ten-year time trends of psychopathology in Dutch children and adolescents: no evidence for strong trends. Acta Psychiatr Scand 96:7-13
27. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463
28. Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS (1980) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30:547-550
29. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J (1996) Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 35:319-324